Since L.E.A.F. began operations in August 2014, the company has filed nearly a dozen patent applications to protect its intellectual property. The first utility patent was published in August 2016 by the US Patent & Trademark Office and, in February 2016, by the World Intellectual Property Organization.
"We are pleased to receive this Health Care Innovator Award because it recognizes the ongoing commitment of our team at L.E.A.F. to apply innovative approaches with state-of-the-art technological advances to the discovery and development of world-class cancer therapies in the Philadelphia area," says Niyikiza.
For more information, please visit www.leafpharmaceuticals.com.
About L.E.A.F. Pharmaceuticals
L.E.A.F. Pharmaceuticals is a global pharmaceutical company with a mission to discover, develop and commercialize innovative and safe therapies for cancer, autoimmune and infectious diseases. L.E.A.F. Pharmaceuticals does also harness scientific advances and breakthroughs in molecular biology and biochemistry, and re-engineers failed, or non-effective but yet promising molecules, with the goal to discover new, safer or more effective medicines.
Media Contact: Raffaella Lo Castro
Logo - http://photos.prnewswire.com/prnh/20161018/430239LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/2016-health-care-innovator-award-presented-to-leaf-pharmaceuticals-300347544.html
SOURCE L.E.A.F. Pharmaceuticals LLC